Background and objective: There is increased use of the 2-min walk test (2MWT) to assess functional exercise capacity. However, the distance achieved during this test may be difficult to interpret in the absence of reference values from a local population. Regression equations to estimate the 2-min walk distance (2MWD) only exist for American and Brazilian populations. The objective of this study was to develop regression equations to estimate the 2MWD in Malaysian adults who were free from major health problems. Methods: Eighty-seven adults (43 males; mean AE SD age: 57.1 AE 9.6 years) performed two 2MWT using a standardized protocol. Heart rate (HR) was recorded every 30 s during the test. Stepwise multiple regression analysis was performed using age, gender, height, weight and change in HR (ΔHR) as independent variables, and better of the two 2MWD as the dependent variable. A second regression equation, without ΔHR, was planned if ΔHR was retained as one of the predictors of the 2MWD in the first equation. Results: The better of the two 2MWD was 200 AE 34 m. Males walked 33 AE 6 m further than females (P < 0.001). The two regression equations were 196 − 1.1 × age, years + 1.0 × ΔHR, bpm + 31.2 × gender (R 2 = 0.73) and 279 − 1.7 × age, years + 35.9 × gender (R 2 = 0.47) with females = 0 and males = 1. Conclusion: The equations derived in this study may facilitate the interpretation of the 2MWD in clinical populations in Malaysia, as well as in countries with similar cultural backgrounds to Malaysia.
INTRODUCTION
In 1982, the 2-min walk test (2MWT) and 6-min walk test (6MWT) were first described as methods to assess functional exercise capacity. 1 These tests were proposed as alternatives to the 12-min walk test (12MWT) as they were considered to be less burdensome for patients with cardiorespiratory disease and less timeconsuming for clinicians to conduct. 1, 2 Over the past 30 years, the 6MWT has emerged as the test of choice as it was better tolerated by patients with cardiorespiratory disease than the 12MWT, and was believed to more accurately reflect the requirements of daily living activities than the 2MWT. 3 Despite its widespread use in patients with stable cardiorespiratory disease, 4 the 6MWT does not appear to be widely used in the management of patients who are hospitalized with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). 5 This may be because clinicians consider the 6MWT to be an inefficient use of their time as the severe dyspnoea that accompanies an exacerbation increases the requirement for patients to rest frequently, or for prolonged periods. Therefore, in the context of patients who experience severe dyspnoea on exertion, such as those who are hospitalized for an AECOPD or those with end-stage cardiorespiratory disease, the 2MWT may be an appropriate alternative to the 6MWT for measuring functional exercise capacity.
Although there are reports of the 2MWT being used to measure functional exercise capacity in clinical populations who are characterized by severe symptoms (e.g. dyspnoea, pain or fatigue), such as those with stable COPD, 6 ,7 poliomyelitis, 8 multiple sclerosis, 9,10 lower
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limb amputation, 11 recent hip fracture, 12 recent cardiac surgery 13 and in the frail elderly, 14, 15 regression equations to estimate the 2-min walk distance (2MWD) are scarce. This limits the capacity to interpret the 2MWD walked by a patient, as a percentage of that achieved in someone without major health problems. In 2007, the global prevalence of COPD of at least moderate severity was 10.1%. 16 Thus, in Malaysia alone, a country with a population of 31.2 million, approximately 3 million adults have COPD. If the uptake of the 2MWD increases in this population, having a regression equation would facilitate interpretation of the test result in very large numbers of individuals. Of the three studies that have reported data on the 2MWD in healthy adults, [17] [18] [19] only two reported regression equations that could be used to estimate the 2MWD. 17, 18 Earlier work has shown that regression equations used to estimate the distance walked in a field-based walking test differ considerably when derived from samples of different ethnicity. 20 The limited capacity of regression equations to estimate values in populations of different ethnicities to that in which they were developed suggests that the two previously published regression equations may be of limited use for individuals from other countries. Therefore, the aim of this study was to develop regression equations to estimate the 2MWD in Malaysian adults. We also sought to compare the 2MWD measured in a Malaysian sample with the 2MWD estimated using the two previously published regression equations.
17,18

METHODS
Design and protocol
Approval to conduct this prospective cross-sectional study was granted by the Human Research Ethics Committees of Curtin University (HR127/2012) and Universiti Teknologi MARA (600-FSK [PT.5/2]). Study participants were volunteers who responded to flyers distributed in four villages in the Batu sub-district, Gombak, Malaysia. Once written informed consent was obtained, data collection was completed during a single 3-h session at any of the four villages, depending on the preference of the participant.
Study criteria
The sample population for this study was 87 Malaysian adults aged between 40 and 75 years. To ensure that our sample was free from any major health problems, the following exclusion criteria were applied: (i) any history of lung cancer, respiratory disease (except for seasonal allergic rhinitis at other times than at the time of study), lung surgery, any heart disease and heart surgery, 21 (ii) taking any of the following medications: anti-arrhythmics, any short-or long-acting bronchodilators, inhaled corticosteroids, mucolytics or antibiotics, 21 (iii) current smokers or ex-smokers with history of >10 pack-years, (iv) upper respiratory tract infection within the past 4 weeks, (v) body mass index (BMI) > 40 kg/m 2 , (vi) use of a gait aid, (vii) presence of significant musculoskeletal or neurological disease likely to compromise performance on the walking test and (viii) an inability to understand either English or Malay. Those who had been prescribed medications for common conditions such as hypertension, hypercholesterolaemia and diabetes mellitus were eligible to participate in this study as these medications are widely used among older adults, and the underlying conditions were unlikely to compromise the 2MWD.
Measurements
On the day of testing, age, gender, body weight (kg) and height (m) were recorded. Spirometry was performed in accordance with a standard protocol using a portable spirometer (KoKo Legend II; nSpire Health Inc., Longmont, CO, USA) to measure forced vital capacity (FVC), forced expiratory volume in 1 s (FEV 1 ) and FEV 1 /FVC. 22 If the value for the FEV 1 /FVC was <0.70, 23 participants were excluded from further testing and were advised to see their doctor.
Two-min walk test
Participants were instructed to continue their usual medications on the day of testing. They were also asked to avoid alcohol and the consumption of a heavy meal for 2 h prior to the testing session, and strenuous physical exercise in the previous 24 h. Before the test, participants were requested to sit for at least 10 min. During this time, measurements were made of resting heart rate (HR; Polar a1, Polar Electro Oy, Kempele, Finland) and blood pressure (Omron M10-IT, Omron Healthcare Europe, Hoofddorp, The Netherlands). A 30-m out and back course was used in this study. All participants performed two 2MWT that were separated by a rest period of at least 20 min. 24, 25 The same investigator supervised both 2MWT. Two 2MWT were performed to account for any improvement resulting from familiarization with the test protocol and the best 2MWD was recorded as the test result.
The 2MWT were carried out in accordance with the protocol for the 6MWT that was available at the commencement of data collection. 26 The protocol was modified to include: (i) standardized encouragement every 30 s instead of every minute, (ii) standardized encouragement every 15 s instead of 30 s to recommence walking if the participant rested during the test and (iii) the instruction to walk 'as fast as you can' instead of 'as far as possible'. HR was recorded every 30 s throughout the test and at test completion. Dyspnoea and leg fatigue were assessed at the end of the test using the modified Borg 0-10 scale. 27 
Statistical analysis
Statistical analyses were performed using the Statistical Package for Social Sciences (SPSS, version 19, SPSS Inc., Chicago, IL, USA) with P < 0.05 used to indicate statistical significance. Data are expressed as mean AE SD or 95% CI unless otherwise stated. A paired samples t-test was used to compare the measures collected between the two 2MWD. The best 2MWD was compared between males and females using an independent t-test. Associations between age, height, weight and change in HR (ΔHR) with the 2MWD were examined using Pearson's correlation coefficients as these variables are associated with the 6-min walk distance (6MWD). [28] [29] [30] Stepwise multiple regression analysis was performed using the variables age, gender, height, weight and ΔHR as the independent variables, and better of the two 2MWD as the dependent variable. A second regression equation, without ΔHR was planned, a priori, if ΔHR was retained in the first equation. This was because an equation that included a measure of cardiac response during the 2MWT may be of limited use when estimating the 2MWD in individuals with a limited chronotropic response to exercise (e.g. heart failure patients or beta-blocker use). The lower limit of normal (LLN) was calculated as the estimated 2MWD −1.64 × residual SD. 31 For all participants, the 2MWD were estimated using the previously published regression equations and these values were compared with the 2MWD measured in the present study using paired samples t-tests. The method described by Bland and Altman 32 was used to examine the agreement between the measured and the estimated 2MWD.
Prospective sample size calculations were based on using multiple regression analyses. In order to have five variables to account for a similar proportion of variance (R 2 = 0.49) in 6MWD as previously described in a healthy Canadian population (α = 0.05, 1 − β = 0.8), 24 a sample size of n = 77 was required. This number was inflated by 15% to take into account the fact that some participants may not complete all the measures related to this study (e.g. two 2MWT in a single session or spirometry). Therefore, the recruitment target for this study was n = 91. Stratified sampling was used to ensure that an equal number of males and females were recruited in each decade of age and the sample was representative of the three major ethnicities in Malaysia (i.e. Malay, Chinese and Indian).
RESULTS
Flow of participants into the study is summarized in Figure 1 . Characteristics of the study participants and the results of their 2MWT are summarized in Table 1 . A total of 37 (43%), 19 (22%) and 18 (21%) participants had been prescribed medications for hypertension, hypercholesterolaemia and diabetes mellitus, respectively. None of the participants required a rest during the 2MWT. The mean 2MWD recorded during the two consecutive 2MWT were 193 AE 33 and 199 AE 34 m, respectively. The 2MWD increased by a mean of 6 m (3%) (95% CI: 4 m (2%) to 8 m (4%)) with test repetition (Appendix S1). Males walked 33 m (18%) (95% CI: 20 m (11%) to 45 m (24%)) further than females (P < 0.001). The 2MWD for each gender across each age strata are presented in Figure S1 (Supplementary Information).
Regression equations
Correlation coefficients between age, height, weight and ΔHR with the 2MWD are shown in Table 2 . The variables that explained the largest proportion of variance in the 2MWD were gender, age and ΔHR (Table 3) Comparison with the 2MWD estimated using the previously published equations
The mean difference between the 2MWD measured in this study and the 2MWD estimated for the study participants using the regression equation established in Brazilian and American adults was 4 m (95% CI: −1 to 10 m) 17 and 23 m (95% CI: 18 to 29 m), 18 respectively. Figure 3 presents the Bland and Altman plots between the 2MWD measured in a Malaysian sample and the 2MWD estimated using both existing equations. Limits of agreement were not calculated due to the presence of proportional bias in the differences.
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15 (17) 15 (35) 0 (0) Non-smoker, n(%)
72 (83) 28 (65) Data are presented as mean AE SD (range) or number (percentage). *P < 0.05 and **P < 0.01 for comparisons between males and females. ΔHR, change in HR (calculated as peak measured HR during the 2MWT − resting HR); %pred HRmax, peak HR expressed as a % HRmax (calculated as 220 − age); 2MWD, 2-min walk distance; 2MWT, 2-min walk test; FEV 1 
DISCUSSION
This is the first study to derive equations to estimate the 2MWD in Malaysian adults who were free from major health problems. This study found that 73% of the variance in the 2MWD was explained by age, gender and ΔHR during the test, and when ΔHR was excluded from the regression equation, the combination of age and gender explained 47% of the variance in the 2MWD. These regression equations will be useful for clinicians who work with adult clinical populations who are characterized by severe symptoms during walking (e.g. dyspnoea, pain or fatigue) and for whom a 2MWT might be a more appropriate test to assess functional exercise capacity. The proportion of variance explained by age and gender was of a similar magnitude to that reported in previous studies that established equations to estimate the 2MWD (i.e. R 2 = 0.51) 17 and the 6MWD (i.e. R 2 between 0.49 and 0.52) 24, 25 in healthy adults. Our finding that the inclusion of ΔHR explained an additional 26% of the variance in the 2MWD over and above that explained using age and gender alone is also consistent with earlier work which has demonstrated that a measure of cardiac response during the 6MWT explains between 13% 25 and 27% 28 of the variance in the 6MWD. The finding that measures of cardiac response during a field-based walking test accounts for a significant proportion of the variability in test performance suggests that cardiac response can be used as a surrogate measure of the participant's effort during the test. 35 Although ΔHR explained a significant proportion of variance in the 2MWD, we consider it important to report both equations so that clinicians can choose to apply the first equation in those who do not have any Gender (male = 1, female = 0). ΔHR, change in HR (calculated as peak measured HR during the 2MWT − resting HR); 2MWD, 2-min walk distance; 2MWT, 2-min walk test; HR, heart rate. reason to suspect chronotropic impairment during the test or the second equation in those who may experience chronotropic impairments during the test (e.g. heart failure patients or beta-blocker use).
The mean 2MWD estimated using the equation derived in an American sample underestimated the mean 2MWD measured in Malaysian adults by 23 m (95% CI: 18-29 m). 18 The reasons for this may relate to differences in test protocol. Specifically, compared with the current study, in the American study only a single 2MWT was performed, the track was shorter (15.2 m vs 30 m) and less frequent encouragement was provided during the test (every 60 s vs 30s). The inclusion of a practice walk, 24, 36 frequency of encouragement during the test 2 and track layout 37, 38 have each been demonstrated to influence 6MWD and these differences in protocol are likely to have optimized the 2MWD achieved in the current study. There was no difference in the mean 2MWD measured in the current study and that estimated using the equation derived in the Brazilian sample. 17 Although when compared with the current study, the Brazilian study also reported using less frequent encouragement, they ensured their participants completed two 2MWT and used a track of similar length, which may explain the similarity in mean 2MWD. In addition to differences in test protocol, the differences in 2MWD between these studies may also reflect parameters that were not assessed in this study such as cardiorespiratory fitness, gait efficiency and motivation.
The Bland and Altman plots showed the presence of proportional bias in the distribution of error between the 2MWD measured in Malaysian adults and the 2MWD estimated using both existing equations. 17, 18 This is despite the similarity in the mean 2MWD measured in the current study and that estimated using the equation derived in the Brazilian sample. 17 Therefore, the two existing equations are unlikely to be suitable for use in the Malaysian population. The presence of proportional bias in the Bland and Altman plot has also been reported in a previous study that compared the 6MWD measured in a sample of North African adults with the 6MWD estimated using regression equations derived from other populations. 39 The selection of participants between 40 and 75 years is likely to limit the generalizability of these equations to estimate the 2MWD in Malaysian adults who are younger than 40 years or older than 75 years. However, this age range was selected as it is representative of patients with COPD who were referred to a pulmonary rehabilitation programme in Malaysia. 40 Additional studies are needed to validate this equation in the Malaysian population.
In conclusion, the equations derived in the current study are the first to estimate the 2MWD in adults living in the Asian region. They are likely to be the most suitable equations to facilitate interpretation of the 2MWD not only in Malaysia but also in other Asian countries with similar cultural backgrounds and anthropometric characteristics, including Indonesia, Singapore and Southern Thailand.
